GSK cuts vaccine price for refugees, bowing to pressure

LONDON (Reuters) – GlaxoSmithKline is cutting the price charged for its pneumococcal vaccine when given to refugees, following complaints about the product’s “exorbitant” cost by medical charity Medecins Sans Frontieres.


Reuters: Health News